PharmaShots | Incisive News in 3 Shots

Subscribe Now

frontotemporal dementia

BMS Signs a Five-Year Agreement with Insitro to Develop Therapies for ALS and Frontotemporal Dementia

BMS Signs a Five-Year Agreement with Insitro to Develop Therapies for ALS and Frontotemporal Dementia

October 29, 2020

Alector's AL101 Receives FDA's Fast Track Designation to Treat Frontotemporal Dementia

Alector's AL101 Receives FDA's Fast Track Designation to Treat Frontotemporal Dementia

February 5, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us